AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.33), $0.01 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $74.6 million versus the consensus estimate of $71.17 million.

GUIDANCE:

AtriCure sees FY2022 revenue of $318-330 million, versus the consensus of $321.7 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.